AI assistant
AGIOS PHARMACEUTICALS, INC. — Director's Dealing 2015
Jul 17, 2015
31580_dirs_2015-07-17_9970804c-ff64-4702-8ac6-c2a42922a59b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AGIOS PHARMACEUTICALS INC (AGIO)
CIK: 0001439222
Period of Report: 2015-07-15
Reporting Person: Cantley Lewis Clayton Jr. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-07-15 | Common stock | S | 2426 | $114.38 | Disposed | 159984 | Direct |
| 2015-07-15 | Common stock | S | 2426 | $114.35 | Disposed | 159984 | Indirect |
| 2015-07-16 | Common stock | S | 2426 | $114.17 | Disposed | 157558 | Direct |
| 2015-07-16 | Common stock | S | 2426 | $114.20 | Disposed | 157558 | Indirect |
Footnotes
F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $113.77 to $115.25. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F3: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $113.47 to $115.25. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F4: Shares held by Vicki Lee Sato, who is the reporting person's spouse.
F5: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $113.24 to $115.15. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F6: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $113.45 to $115.20. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.